A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)

Clinical trial NCT04530643 · COMPLETED

Trial details

NCT number: NCT04530643
Sponsor: Shaperon
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2020-08-26
Primary completion: 2021-09-07
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.